Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPBWR1 | P48145 | 1/20 | 0.38 |
| ▸ | SCD | O00767 | 3/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.34 |
| ▸ | ACP1 | P24666 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | ERN1 | O75460 | 1/20 | 0.33 |
| ▸ | PDE5A | O76074 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3223168 | 0.68 | MAPT (0.56) | PTGS2 | |
| SCHEMBL31733573 | 0.66 | PRKDC (0.44) | NPBWR1SCDPTGS2LMNAERN1 | |
| SCHEMBL3230905 | 0.66 | MEN1 (0.50) | PTGS2LMNA | |
| SCHEMBL23903922 | 0.65 | OGA (0.46) | NPBWR1SCD | |
| SCHEMBL3220143 | 0.65 | ATM (0.43) | NPBWR1SCDPTGS2ALOX5ACSS2 | |
| SCHEMBL11377378 | 0.65 | SCD (0.43) | NPBWR1SCDLMNAACSS2 | |
| SCHEMBL14089193 | 0.64 | MEN1 (0.51) | NPBWR1LMNA | |
| SCHEMBL15814013 | 0.64 | ALDH1A1 (0.43) | PTGS2LMNAERN1 | |
| SCHEMBL12593470 | 0.64 | SMN1; SMN2 (0.52) | NPBWR1PTGS2LMNAERN1 | |
| SCHEMBL17442805 | 0.62 | NPBWR1 (0.38) | NPBWR1SCDACP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118344423-A | Compositions and methods for targeting CNS disorders | 萨奇治疗股份有限公司 | 2024-07-16 | — | — | CN | disclosed |